As filed with the Securities and Exchange Commission on August 2, 2023
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
AMARIN CORPORATION PLC
(Exact name of registrant as specified in its charter)
|
|
|
England and Wales |
|
Not Applicable |
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification No.) |
Iconic Offices, The Greenway, Block C Ardilaun Court,
112-114 St Stephens Green
Dublin 2, Ireland
+353
(0) 1 6699 020
(Address, including zip code, and telephone number, including area code, of registrants principal executive
offices)
Amarin Corporation plc 2020 Stock Incentive Plan
(Full title of the plans)
Patrick Holt
President
and Chief Executive Officer
Amarin Corporation plc
c/o Amarin Pharma, Inc.
440 Route 22
Bridgewater, NJ 08807
Telephone: (908) 719-1315
(Name, address, and telephone number, including area code, of agent for service)
Please send copies of all communications to:
Michael H. Bison, Esq.
Jacqueline Mercier, Esq.
Finnbarr D. Murphy, Esq.
Goodwin Procter LLP
100
Northern Avenue
Boston, MA 02210
Telephone: (617) 570-1000
Facsimile: (617) 523-1231
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer |
|
☒ |
|
Accelerated filer |
|
☐ |
|
|
|
|
Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
☐ |
|
|
|
|
|
|
|
|
Emerging growth company |
|
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐